Bluejay Diagnostics (BJDX) Competitors $3.57 +0.22 (+6.57%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsShort InterestTrends BJDX vs. MHUA, ALUR, STRR, TTOO, PSTV, PAVM, INBS, TNON, SINT, and NUWEShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Meihua International Medical Technologies (MHUA), Allurion Technologies (ALUR), Star Equity (STRR), T2 Biosystems (TTOO), Plus Therapeutics (PSTV), PAVmed (PAVM), Intelligent Bio Solutions (INBS), Tenon Medical (TNON), Sintx Technologies (SINT), and Nuwellis (NUWE). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Meihua International Medical Technologies Allurion Technologies Star Equity T2 Biosystems Plus Therapeutics PAVmed Intelligent Bio Solutions Tenon Medical Sintx Technologies Nuwellis Meihua International Medical Technologies (NASDAQ:MHUA) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation. Does the MarketBeat Community prefer MHUA or BJDX? Bluejay Diagnostics received 2 more outperform votes than Meihua International Medical Technologies when rated by MarketBeat users. CompanyUnderperformOutperformMeihua International Medical TechnologiesN/AN/ABluejay DiagnosticsOutperform Votes266.67% Underperform Votes133.33% Do insiders & institutionals believe in MHUA or BJDX? 1.2% of Meihua International Medical Technologies shares are held by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are held by institutional investors. 66.6% of Meihua International Medical Technologies shares are held by company insiders. Comparatively, 0.4% of Bluejay Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is MHUA or BJDX more profitable? Meihua International Medical Technologies' return on equity of 0.00% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Meihua International Medical TechnologiesN/A N/A N/A Bluejay Diagnostics N/A -155.67%-117.82% Which has better valuation & earnings, MHUA or BJDX? Meihua International Medical Technologies has higher revenue and earnings than Bluejay Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeihua International Medical Technologies$97.10M0.08$11.62MN/AN/ABluejay Diagnostics$250K7.85-$9.95M-$1.37 thousand0.00 Which has more risk & volatility, MHUA or BJDX? Meihua International Medical Technologies has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, Bluejay Diagnostics has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Does the media prefer MHUA or BJDX? In the previous week, Meihua International Medical Technologies' average media sentiment score of 0.00 equaled Bluejay Diagnostics'average media sentiment score. Company Overall Sentiment Meihua International Medical Technologies Neutral Bluejay Diagnostics Neutral SummaryMeihua International Medical Technologies beats Bluejay Diagnostics on 6 of the 9 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.96M$4.83B$5.39B$9.13BDividend YieldN/A52.58%5.37%4.00%P/E Ratio0.0026.8889.0817.53Price / Sales7.8559.841,255.34136.91Price / CashN/A50.8936.6032.90Price / Book0.007.904.964.69Net Income-$9.95M$13.87M$117.89M$224.57M7 Day Performance2.88%2.34%1.72%1.69%1 Month Performance-7.03%11.37%3.66%5.34%1 Year Performance-98.97%32.02%25.79%21.47% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics0.5747 of 5 stars$3.57+6.6%N/A-99.0%$1.96M$250,000.000.009Gap UpMHUAMeihua International Medical Technologies1.0187 of 5 stars$0.31-3.8%N/A-64.7%$7.78M$94.25M0.00620Positive NewsALURAllurion Technologies3.3911 of 5 stars$2.97-22.4%$71.88+2,323.3%-96.2%$7.69M$34.75M-6.18501News CoverageSTRRStar EquityN/A$2.19-1.4%N/A-54.9%$7.05M$45.78M-0.85460Gap UpTTOOT2 Biosystems1.6614 of 5 stars$0.32flat$5.00+1,462.5%-94.8%$6.73M$7.68M0.00180Analyst ForecastNews CoverageGap UpPSTVPlus Therapeutics2.0756 of 5 stars$1.13-2.6%$13.50+1,094.7%-42.3%$6.67M$4.91M-0.4520Positive NewsPAVMPAVmed4 of 5 stars$0.60-1.3%$19.00+3,066.7%-76.1%$6.64M$4.03M-0.1490News CoveragePositive NewsINBSIntelligent Bio Solutions1.4072 of 5 stars$1.32-0.8%N/A-64.6%$5.79M$3.19M0.0010Short Interest ↓News CoveragePositive NewsTNONTenon Medical2.3662 of 5 stars$1.73-6.0%$5.50+217.9%+29.9%$5.43M$3.32M-0.068SINTSintx Technologies0.0755 of 5 stars$3.36-0.9%N/A-94.6%$4.51M$1.64M-0.0740Positive NewsGap DownNUWENuwellis2.9051 of 5 stars$1.01-1.0%$17.00+1,583.2%-92.5%$4.42M$8.97M-0.0170 Related Companies and Tools Related Companies Meihua International Medical Technologies Alternatives Allurion Technologies Alternatives Star Equity Alternatives T2 Biosystems Alternatives Plus Therapeutics Alternatives PAVmed Alternatives Intelligent Bio Solutions Alternatives Tenon Medical Alternatives Sintx Technologies Alternatives Nuwellis Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BJDX) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
